CClinicalTrials.gg
Not yet recruitingNCT06909552Updated Jul 25, 2025

Use of an Educational Video to Improve Adherence to Treatment in Voiding Dysfunction

An interventional study of Educational Video on Voiding Dysfunction in Dysfunctional Voiding, sponsored by University of Colorado, Denver. Not yet recruiting at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-07-25.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Study summary

This study aims to see whether an educational video on a common urinary dysfunction leads to improved parent and child perceived adherence to treatments recommendations.

Read the detailed description

This study aims to explore whether the use of an educational video on voiding dysfunction, a common urinary dysfunction, leads to improve parents and child perceived adherence to behavioral treatment recommendations. Our main hypothesis explores whether there is improved perceived adherence, and whether this improved perceived adherence leads to better symptom outcomes in this condition.

We do so through randomizing patients to a control and intervention group, where the latter is exposed to the educational video, while the control group experiences standard of care visits/follow-ups. Data is collected through surveys pre and post exposure to the intervention.

02

Conditions studied

  • Dysfunctional Voiding

Keywords

  • dysfunctional voiding
  • educational video
  • treatment adherence
  • behavioral modification
03

In context

Treatment Adherence and Compliance

114 studies on the registry are indexed under Treatment Adherence and Compliance; 60 are open to participants now.

This study's planned enrollment of 100 is above the median of 84 across 97 interventional studies indexed under Treatment Adherence and Compliance.

Browse Treatment Adherence and Compliance studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,499 studies on the registry; 315 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 89 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Parents and Caregivers of pediatric urology patients with a diagnosis of Dysfunctional voiding (minimum 100 participants)
  • 5-18 years old, no younger than 5 and no older than 18 years old
  • Potty-trained - fully independent with toileting, can complete every step of the process and can do so satisfactorily by themselves.

Exclusion criteria

Exclusion Criteria:

  • Children with Voiding dysfunctionDysfunctional voiders with medically complex conditions (neurogenic bladder, POTS, EDS, etc.)
  • Parent's child is notNot a first-time patient (i.e. has been seen in the past for dysfunctional voiding)
  • Child has severeSevere intellectual disability, developmental delay, or cognitive impairment.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Educational Video

    Participants will be exposed to a short 3-minute educational video following a visit with their urology provider.

    Other: Educational Video on Voiding Dysfunction

  • No intervention
    Control

    Participants will not be exposed to an educational video; rather, they will receive standard of care education in clinic regarding behavioral treatment modalities at home.

Interventions

  • OtherEducational Video on Voiding Dysfunction

    The educational video is a short 3-minute video which describes the condition in detail, at the level that a parent or child could understand without a medical background.

06

What researchers measure

Primary outcomes

  1. Perceived Adherence

    Participants will take the TAPQ perceived adherence assessment at time points 4 weeks and 8 weeks.

    Time frame: 4 weeks, 8 weeks.

Secondary outcomes

  1. Video Acceptability

    Immediately after watching the educational video, participants will be asked to complete a questionnaire on the acceptability of the video. this will occur at time frame 0 weeks (for intervention group).

    Time frame: 0 weeks.

  2. Dysfunctional Voiding Scoring System

    Participants will be asked to complete a DVSS survey at timepoints 0 weeks, 4 weeks, and 8 weeks. This DVSS survey will be used to assess symptom improvement throughout the study.

    Time frame: 0 weeks, 4 weeks, and 8 weeks.

07

Study locations

1 site
08

References and documents

Publications

  • Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr. 2006 Apr;18(2):139-47. doi: 10.1097/01.mop.0000193289.64151.49. PubMed 16601493 ↗
  • Dyson PA, Beatty S, Matthews DR. An assessment of lifestyle video education for people newly diagnosed with type 2 diabetes. J Hum Nutr Diet. 2010 Aug;23(4):353-9. doi: 10.1111/j.1365-277X.2010.01077.x. Epub 2010 May 20. PubMed 20497292 ↗

Individual participant data

Plan to share: No — resource limitations

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06909552
Lead sponsor
University of Colorado, Denver
Responsible party
Sponsor
First posted
Apr 3, 2025
Start date
Aug 1, 2025 (estimated)
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Jul 25, 2025

Study contacts

Marguerite Korber, CPNP
Contact
marguerite.korber@childrenscolorado.org
720-777-6523

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion